Company intelligence / Profile preview

Xicheng Jinrui Equity Investment Fund

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Xicheng Jinrui Equity Investment Fund is a Beijing-based professional private equity/venture investment manager that raises capital from institutional and individual investors and allocates it into private companies, including multiple biotech and healthcare firms in China.

Industry: Investors

Partnerships

Acts as lead or co-lead investor with firms such as Shenzhen GTJA Investment Group, Efung Capital, Suzhou Oriza Holdings, Sequoia Capital China and others in biotech financings (e.g., Atom Bioscience, IMPACT Therapeutics).

Beyond the preview

Go deeper on Xicheng Jinrui Equity Investment Fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Xicheng Jinrui Equity Investment Fund.

Explore the full profile